Smokers with myelodysplastic syndromes or a precursor condition had elevated levels of genetic mutations linked to the disease. The study also found that heavier smokers accumulated more mutations, and long-term smokers were more likely to show disease progression.
Tag: Genetic Mutations
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
NCCN expands guidelines to create two major resources for helping cancer care providers and other stakeholders stay current on cutting edge research on genetic/familial high-risk assessment.
Am I too Young for a Mammogram?
While routine mammograms are generally recommended starting at age 40, there are certain factors that may make it necessary to get screened at a younger age. Learn more about these factors that may prompt younger women to consider getting screened earlier.
Shrinking statures, growing insights: unraveling the genetic underpinnings of dwarfism in squash
Unlocking the secrets of nature, a pioneering study has pinpointed a gene mutation with profound implications for plant height and stress tolerance. The discovery lies in the CpDWF5 gene, whose alteration leads to a compact squash plant with a unique resistance to salt stress, marking a leap forward in agricultural science.
Head injuries could be a risk factor for developing brain cancer
Researchers from the UCL Cancer Institute have provided important molecular understanding of how injury may contribute to the development of a relatively rare but often aggressive form of brain tumour called a glioma.
New technique makes gene editing at scale possible in animals, turning years of work into days and making new kinds of genetic experiments possible
A new gene editing technique developed by University of Oregon researchers compresses what previously would have been years of work into just a few days, making new kinds of research possible in animal models.
Identifying the Underlying Causes of Ovarian Cancer
Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women’s tumors do not respond to therapy.
Scientists unravel genetic mystery of rare neurodevelopmental disorder, provide definitive diagnoses to 21 families worldwide
A collaborative team of scientists led by Mayo Clinic’s Center for Individualized Medicine has discovered 15 additional genetic mutations in the KCNK9 gene that cause a neurodevelopmental syndrome.
All About Eve
New AI model called EVE, developed by scientists at Harvard Medical School and Oxford University, outperforms other AI methods in determining whether a gene variant is benign or disease-causing.
When applied to more than 36 million variants across 3,219 disease-associated proteins and genes, EVE indicated more than 256,000 human gene variants of unknown significance that should be reclassified as benign or pathogenic.
‘Research autopsy’ helps scientists study why certain cancer therapies stop working
A new research study at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death.
Albert Einstein College of Medicine Awarded $5 Million for Research on Intellectual and Developmental Disabilities
Albert Einstein College of Medicine has received a five-year, $5 million grant from the National Institutes of Health (NIH) to support the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK IDDRC), which has been at the forefront of research on normal and abnormal brain development for more than 50 years.
WHERE TROUBLE STARTS
In the earliest hours of your embryonic status, cells were developing and multiplying, critical processes were starting up, networks were connecting and genetic codes — for better or worse — were directing the whole project.
That early development is the focus of University of Delaware biologist Shuo Wei’s research. Now his work has won more than $1.8 million in support from the National Institutes of Health.